<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Coinfection with <z:e sem="disease" ids="C0024535" disease_type="Disease or Syndrome" abbrv="">Plasmodium falciparum malaria</z:e> and Epstein-Barr virus (EBV) is a major risk factor for endemic Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (eBL), still one of the most prevalent <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">pediatric cancers</z:e> in equatorial Africa </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> has been associated with immunosuppression, the precise mechanisms that contribute to EBV-associated <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> remain unclear </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we used polychromatic flow cytometry to characterize CD8(+) T-cell subsets specific for EBV-derived lytic (BMFL1 and BRLF1) and latent (LMP1, LMP2, and EBNA3C) antigens in individuals with divergent <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposure </plain></SENT>
<SENT sid="3" pm="."><plain>No <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>-associated differences in EBV-specific CD8(+) T-cell frequencies were observed </plain></SENT>
<SENT sid="4" pm="."><plain>However, based on a multidimensional analysis of CD45RO, CD27, CCR7, CD127, CD57, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 expression, we found that individuals living in regions with intense and perennial (holoendemic) <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> transmission harbored more differentiated EBV-specific CD8(+) T-cell populations that contained fewer central memory cells than individuals living in regions with little or no (hypoendemic) <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>This profile shift was most marked for EBV-specific CD8(+) T-cell populations that targeted latent antigens </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposure did not skew the phenotypic properties of either cytomegalovirus (CMV)-specific CD8(+) T cells or the global CD8(+) memory T-cell pool </plain></SENT>
<SENT sid="7" pm="."><plain>These observations define a <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>-associated aberration localized to the EBV-specific CD8(+) T-cell compartment that illuminates the etiology of eBL </plain></SENT>
</text></document>